302 related articles for article (PubMed ID: 19396052)
1. What have the 'omics done for endometriosis?
Siristatidis CS
Med Sci Monit; 2009 May; 15(5):RA116-23. PubMed ID: 19396052
[TBL] [Abstract][Full Text] [Related]
2. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
3. Proteomics technologies in endometriosis.
Ferrero S; Gillott DJ; Remorgida V; Ragni N; Venturini PL; Grudzinskas JG
Expert Rev Proteomics; 2008 Oct; 5(5):705-14. PubMed ID: 18937560
[TBL] [Abstract][Full Text] [Related]
4. Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.
Singh MP; Patel S; Dikshit M; Gupta YK
Indian J Biochem Biophys; 2006 Apr; 43(2):69-81. PubMed ID: 16955754
[TBL] [Abstract][Full Text] [Related]
5. OMICS-driven biomarker discovery in nutrition and health.
Kussmann M; Raymond F; Affolter M
J Biotechnol; 2006 Aug; 124(4):758-87. PubMed ID: 16600411
[TBL] [Abstract][Full Text] [Related]
6. Genomics and proteomics in predicting cancer outcomes.
Parikh AA; Johnson JC; Merchant NB
Surg Oncol Clin N Am; 2008 Apr; 17(2):257-77, vii. PubMed ID: 18375352
[TBL] [Abstract][Full Text] [Related]
7. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
8. Challenges of genomics and proteomics in nephrology.
Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of endometriosis.
Bischoff F; Simpson JL
Ann N Y Acad Sci; 2004 Dec; 1034():284-99. PubMed ID: 15731320
[TBL] [Abstract][Full Text] [Related]
10. Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis.
Ametzazurra A; Matorras R; García-Velasco JA; Prieto B; Simón L; Martínez A; Nagore D
Hum Reprod; 2009 Apr; 24(4):954-65. PubMed ID: 19095664
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
12. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
[TBL] [Abstract][Full Text] [Related]
13. Genetics, genomics and proteomics in atherosclerosis research.
Tuomisto TT; Binder BR; Ylä-Herttuala S
Ann Med; 2005; 37(5):323-32. PubMed ID: 16179268
[TBL] [Abstract][Full Text] [Related]
14. Genomics and vaccine development.
Gay CG; Zuerner R; Bannantine JP; Lillehoj HS; Zhu JJ; Green R; Pastoret PP
Rev Sci Tech; 2007 Apr; 26(1):49-67. PubMed ID: 17633293
[TBL] [Abstract][Full Text] [Related]
15. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
16. Uncharacterized/hypothetical proteins in biomedical 'omics' experiments: is novelty being swept under the carpet?
Pawłowski K
Brief Funct Genomic Proteomic; 2008 Jul; 7(4):283-90. PubMed ID: 18641417
[TBL] [Abstract][Full Text] [Related]
17. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
18. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
19. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Kulasingam V; Diamandis EP
Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
[TBL] [Abstract][Full Text] [Related]
20. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
Qoronfleh MW
Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
